))
Genomic Testing and Tools with Barnaby Balmforth, PhD
Manage episode 408113996 series 3560286
内容由Healio, Shikha Jain, and MD提供。所有播客内容（包括剧集、图形和播客描述）均由 Healio, Shikha Jain, and MD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
In this episode, host Shikha Jain, MD, speaks with Barnaby Balmforth, PhD, about the evolution of genomics in cancer care, the impact of personalized care tools and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Balmforth 1:12 • The interview 3:01 • How did you get to where you are today? What drove you to become a leader in this space? 3:45 • What is genomics, and why is genomic analysis important in cancer care? 7:18 • Jain and Balmforth on the evolution of technology and challenges facing genomics and diagnostic testing to achieve personalized care for individual patients. 11:59 • In addition to time, can you speak on the challenge of access for this type of technology? 13:20 • How have you been able to implement “next day” test results and reports of your technology? 17:50 • Jain and Balmforth on how Biofidelity’s technology can transform the delivery of care, as well as its psychological and mental impact. 19:06 • What’s coming down the line for you and Biofidelity? 20:56 • What are your thoughts for when you expand beyond thoracic oncology? What are your long-term visions for other disease sites? 24:19 • Do you have any thoughts on AI and how it may influence genomics in cancer care? 25:51 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:37 • How to contact Balmforth 30:37 • Thanks for listening 31:10 Barnaby Balmforth, PhD, is co-founder and CEO of Biofidelity. Barnaby has more than 15 years’ experience in the leadership of multidisciplinary technology development.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Balmforth can be reached via the Biofidelity website. Disclosures: Jain reports no relevant financial disclosures. Balmforth reports he is an employee of Biofidelity and owns shares in the company.
100集单集
分享
